Insider Trading & Ownership - RIEDEL NORBERT G

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for RIEDEL NORBERT G
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-14
Sale
2023-08-15
5:58 pm
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
1,241$138.16$171,45413,705
(Direct)
View
2022-08-05
Sale
2022-08-09
6:38 pm
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
9,089$155.44$1,412,79711,871
(Direct)
View
2021-12-06
Purchase
2021-12-08
4:16 pm
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
100,000$2.23$223,0001,355,873
(Indirect
Direct)
View
2021-08-06
Sale
2021-08-10
5:38 pm
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
1,306$147.96$193,23610,399
(Direct)
View
2020-08-07
Sale
2020-08-10
4:50 pm
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
931$125.87$117,18616,224
(Direct)
View
2020-01-10
Purchase
2020-01-14
4:23 pm
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO and President
35,000$3$105,0001,003,147
(Indirect
Direct)
View
2019-08-09
Sale
2019-08-12
5:32 pm
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
726$135.65$98,48212,490
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-13
Option Award
2024-02-15
4:15 pm
N/A
2034-02-12
Eton Pharmaceuticals Inc.ETONRIEDEL NORBERT G
Director
30,000$0164,555
(Direct)
View
2023-08-11
Option Award
2023-08-15
5:58 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
3,075$013,705
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:15 pm
N/A
2033-06-07
Cerevel Therapeutics Holdings Inc.CERERIEDEL NORBERT G
Director
17,062$059,872
(Direct)
View
2023-03-03
Option Award
2023-03-03
4:10 pm
N/A
2033-02-19
Eton Pharmaceuticals Inc.ETONRIEDEL NORBERT G
Director
25,000$0134,555
(Direct)
View
2023-01-03
Option Award
2023-01-05
4:17 pm
N/A
2033-01-02
Aptinyx Inc.APTXRIEDEL NORBERT G
EXECUTIVE CHAIRMAN OF THE BOD
420,000$0420,000
(Direct)
View
2022-08-05
Exercise
2022-08-09
6:38 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
8,000$55.2811,871
(Direct)
View
2022-08-05
Option Award
2022-08-09
6:38 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
2,561$011,871
(Direct)
View
2022-08-05
Exercise
2022-08-09
6:38 pm
N/A
2023-05-08
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
8,000$011,871
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:49 pm
N/A
2032-06-14
Cerevel Therapeutics Holdings Inc.CERERIEDEL NORBERT G
Director
23,459$023,459
(Direct)
View
2022-02-07
Option Award
2022-02-28
4:34 pm
N/A
2032-02-07
Eton Pharmaceuticals Inc.ETONRIEDEL NORBERT G
Director
50,000$0109,555
(Direct)
View
2022-01-04
Exercise
2022-01-06
4:31 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc.CERERIEDEL NORBERT G
Director
14,270$042,810
(Direct)
View
2021-12-02
Option Award
2021-12-07
4:16 pm
N/A
2031-12-01
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
475,000$0475,000
(Direct)
View
2021-07-29
Option Award
2021-08-02
6:25 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
2,246$011,705
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:14 pm
N/A
2031-06-10
Cerevel Therapeutics Holdings Inc.CERERIEDEL NORBERT G
Director
58,003$058,003
(Direct)
View
2021-05-17
Exercise(A)
2021-05-20
5:53 pm
N/A
N/A
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
380,000$01,255,873
(Direct)
View
2021-05-17
Tax Withholding(A)
2021-05-20
5:53 pm
N/A
N/A
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
127,274$2.531,255,873
(Direct)
View
2021-05-17
Exercise
2021-05-19
6:46 pm
N/A
N/A
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
380,000$0615,265
(Direct)
View
2021-05-17
Tax Withholding
2021-05-19
6:46 pm
N/A
N/A
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
127,274$2.53615,265
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:15 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc.ETONRIEDEL NORBERT G
Director
19,655$059,555
(Direct)
View
2021-02-24
Option Award
2021-02-26
7:34 pm
N/A
2031-02-23
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO
733,300$0733,300
(Direct)
View
2021-01-04
Exercise
2021-01-06
4:26 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc.CERERIEDEL NORBERT G
Director
14,270$042,810
(Direct)
View

Ownership
2020-10-30
7:51 pm
N/A
N/A
Cerevel Therapeutics Holdings Inc.CERERIEDEL NORBERT G
Director
0$042,810
(Direct)
View
2020-08-06
Option Award
2020-08-10
4:50 pm
N/A
2030-08-05
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
9,470$016,224
(Direct)
View
2020-03-12
Option Award
2020-03-16
4:52 pm
N/A
2030-03-11
Eton Pharmaceuticals Inc.ETONRIEDEL NORBERT G
Director
27,400$027,400
(Direct)
View
2020-02-26
Option Award
2020-02-28
4:34 pm
N/A
2030-02-25
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO and President
625,000$0625,000
(Direct)
View
2019-08-08
Option Award
2019-08-12
5:32 pm
N/A
2029-08-07
Jazz Pharmaceuticals plcJAZZRIEDEL NORBERT G
Director
6,725$012,490
(Direct)
View
2019-05-16
Option Award
2019-05-17
7:01 pm
N/A
N/A
Aptinyx Inc.APTXRIEDEL NORBERT G
CEO and President
380,000$0380,000
(Direct)
View
(A) Indicate amendment filing.